N4 Pharma (N4P)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

3.30p
   
  • Change Today:
      0.30p
  • 52 Week High: 3.50
  • 52 Week Low: 0.43
  • Currency: UK Pounds
  • Shares Issued: 101.46m
  • Volume: 594,266
  • Market Cap: 3.35m

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (m) Pre-tax (m) EPS Dividend
30-Jun-19 Interim n/a (0.55) (0.56)p n/a

Key Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 n/a (0.01) (0.86)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (0.16) (9.08)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (0.19) (8.00)p n/a n/a n/a n/a 0.0%
31-Dec-17 0.11 (1.93) (1.26)p n/a n/a n/a n/a 0.0%
31-Dec-18 0.07 (1.39) (1.32)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-20 n/a n/a n/a n/a n/a n/a n/a 0.0%
31-Dec-21 n/a n/a n/a n/a n/a n/a n/a 0.0%

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

N4 Pharma Market Data

Currency UK Pounds
Share Price 3.30p
Change Today 0.30p
% Change 10.00 %
52 Week High 3.50
52 Week Low 0.43
Volume 594,266
Shares Issued 101.46m
Market Cap 3.35m

N4 Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Value
38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average38.2% below the market average
68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average68.42% below the sector average
Income Not Available
Growth
24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average24.75% below the market average
35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average35.14% below the sector average

N4 Pharma Dividends

No dividends found

Trades for 20-Jan-2020

Time Volume / Share Price
14:46 14,130 @ 3.45p
14:41 50,000 @ 3.31p
14:36 50,000 @ 3.41p
14:15 30,000 @ 3.40p
14:11 27,714 @ 3.50p

N4 Pharma Key Personnel

CEO Nigel Theobald

Top of Page